HIF-1α and ENPP2 as Biomarkers in Chemotherapy Resistance of Children with Neuroblastoma in south Iraq
Abstract
Background: The most common extra-cranial solid tumor in kids, Neuroblastoma (NB) accounts for 10% of all pediatric oncology fatalities. It emerges in the embryonic neural crest due to the uncontrolled behavior of sympathetic nervous system progenitors, giving rise to heterogeneous tumors. Although immunotherapy and targeted therapy have advanced quickly, surgery, chemotherapy, and radiation (RT) still make up the majority of first-line options for treating cancer. Recurrence of the illness and diminished efficacy of chemotherapy and RT are among the factors that contribute to treatment failure. This study was aimed at evaluating the effects HIF-1α, ENPP2 and oxidant / antioxidant of chemotherapy resistance with NB children.
Methods: This study extended from May 2022 to end of March 2023, with age range 2 months to 12 years. 70 children (male/ female) were divided into three groups. Group A: includes 35 healthy children as control group, and group B: includes 35 patients of Newly diagnosed and group C: after three cycles of chemotherapy. Detailed information regarding the age and gender was recorded for every participant.
Results: The present study's findings showed a considerable rise in (p˂0.05) at the levels of HIF-1α, MDA, ENPP2 while the outcomes showed a statistically significant decrease (p˂0.05) at the levels of GSH, in the sera samples of patients with NB (pre-treatment) when compared to the control group. The findings, on the other hand, demonstrate that each of the following parameters—HIF-1, MDA, and GSH—decreased in levels in NB patients after receiving chemotherapy dosages. Nevertheless, following therapy, ENPP2 levels increased.
Conclusion: Our findings are indicative of the fact that early diagnosis plays an important role in the effectiveness of chemotherapy. and the levels of oxidant- anti oxidant status, HIF-1α and ENPP2 are significant features of the monitoring of disease progression and the efficacy of treatment.
Full Text:
PDFReferences
Cimmino F, Pezone L, Avitabile M, Acierno G, Andolfo I, Capasso M, et al. Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells. scientific reports, (2015); 5(11158): 1–15.
Sabah M, Rahman A, Hasan JG, Samad AA, Salih HM. Pattern of Neuroblastoma Among Children in Basra Pediatric Oncology Center. Archives of Cancer Research and Medicine, (2020); 1(1): 1-14.
Barr EK, Applebaum MA. Genetic predisposition to neuroblastoma. Children, (2018); 5(9): 1–18.
Laura B, Radu B, Patricia C, Andreea M. Association of Image-Defined Risk Factors with Clinical , Biological Features and Outcome in Neuroblastoma. Children, (2022); 9(1707): 1–12.
Vega FM, Huertas-Castaño C, Gómez-Muñoz MA, Pardal R. Hypoxia in the initiation and progression of neuroblastoma tumours. International Journal of Molecular Sciences, (2020); 21(1): 1-15.
Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Molecular Cancer, (2022); 21(1):1–22.
Pialoux V, Mounier R, Brown AD, Steinback CD, Rawling JM, Poulin MJ. Free Radical Biology & Medicine Relationship between oxidative stress and HIF-1 α mRNA during sustained hypoxia in humans. Free Radical Biology & Medicine journal, (2009); 46(2): 321–326.
Zaid Ak., Sayer SA. Association Abnormal Levels of Serum Interleukin-33, Interleukin-23 with Oxidant-Antioxidants Status in patients with Acute Liver Failure. University of Thi-Qar Journal of Science, (2022); 9(2): 94–99.
Li H, Zhou Y, Li L, Li S, Long D, Chen X, et al. Redox Biology HIF-1 α protects against oxidative stress by directly targeting mitochondria. Redox Biology journal, (2019); 2213(2317): 1-15.
Prijanti AR, Iswanti FC, Ferdinal F, Jusman SWA, Soegianto RR, Wanandi SI, et al. Hypoxia increased malondialdehyde from membrane damages is highly correlated to HIF-1α but not to renin expression in rat kidney. Earth and Environmental Science, (2019); 217(012062): 1–10.
Alqader S. Comparison of plasma lipid peroxidation between migraine and tension type headache in Iraqi patients. University of Thi-Qar Journal of Science, (2013) ;3(4):74–83.
Janion K, Strzelczyk JK, Walkiewicz KW, Biernacki K, Copija A, Szczepańska E, et al. Evaluation of Malondialdehyde Level, Total Oxidant/Antioxidant Status and Oxidative Stress Index in Colorectal Cancer Patients. Metabolites, (2022); 12(1118):1–10.
Martemucci G, Costagliola C, Mariano M, D’andrea L, Napolitano P, D’Alessandro AG. Free Radical Properties, Source and Targets, Antioxidant Consumption and Health. Oxygen, (2022); 2(2): 48–78.
Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro A, Pronzato M, Marinari UM, Domenicotti C. Role of Glutathione in Cancer Progression and Chemoresistance. Oxidative Medicine and Cellular Longevity, (2013); 2013: 1-11.
Honda T, Coppola S, Ghibelli L, Cho S, Kagawa S, Spurgers K, Brisbay S, Roth J, Meyn R, Mcdonnell T. GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells. Cancer Gene Therapy, (2004); 11: 249–255.
Wang J, Green PS, Simpkins JW. Estradiol protects against ATP depletion , mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. Journal of Neurochemistry, 2001; 77: 804–811.
Corso CR, Acco A. Glutathione system in animal model of solid tumors: From regulation to therapeutic target. Critical Reviews in Oncology / Hematology, (2018); 128: 43–57.
Harper K, Brochu-gaudreau K, Saucier C, Dubois CM. Hypoxia Downregulates LPP3 and Promotes the Cell Invasion. Cancers, (2019); 11(1403): 1–19.
Banerjee S, Lee S, Norman DD, Tigyi GJ. Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis. Molecules, (2022); 27(5487): 1–16.
Drosouni A, Panagopoulou M, Aidinis V, Chatzaki E. Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications. Cancers, 2022; 14(5437): 1–14.
Panagopoulou M, Fanidis D, Aidinis V, Chatzaki E. Enpp2 methylation in health and cancer. International Journal of Molecular Sciences. 2021; 22(11958.): 1–21.
Fong K, McCay P, Poyer J. Oxidative stress. Free Rad Journal of Biological Chemistry, (1973); 248(22): 7792-7797.
Qu M, Long Y, Wang Y, Yin N, Zhang X, Zhang J. Hypoxia Increases ATX Expression by Histone Crotonylation in a HIF-2 α -Dependent Manner. International Journal of Molecular Sciences, (2023); 24(7031): 1–15.
Yin CP, Guan SH, Zhang B, Wang XX, Yue SW. Upregulation of HIF-1α protects neuroblastoma cells from hypoxia-induced apoptosis in a RhoA-dependent manner. Molecular Medicine Reports, (2015); 12(5): 7123–7131.
Han S, Huang T, Hou F, Yao L, Wang X, Wu X. The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis Susu. Therapeutic Advances in Medical Oncology, (2019); 11: 1-21.
Zhao J, Feng D, Yang L, Shen G, Zheng F, Xu B. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors. Cancer Treatment Reviews, (2015); 41(7): 623–633.
Klymenko T, Brandenburg M, Morrow C, Dive C, Makin G. The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cells. Molecular Cancer Therapeutics, (2011); 10(12): 2373–2383.
Afsar CU, Uysal P. HIF-1 a Levels in patients receiving chemoradiotherapy for locally advanced non-small cell lung carcinoma. Revista da Associacao Medica Brasileira, (2019); 65(10): 1295–1299.
El-Sabagh ME, Ramadan KS, Ibrahim AM. Antioxidants Status in Acute Lymphoblastic Leukemic Patients. American Journal of Medicine and Medical Sciences, (2011); 1(1):1–6.
Luiz A, Júnior G, Fernanda M, Jardim C, Iasmin L, Carvalho S, et al. Serum Oxidative Stress Markers and Genotoxic Profile Induced by Chemotherapy in Patients with Breast Cancer : A Pilot Study. H Oxidative Medicine and Cellular Longevity, 2015; 1–11.
Kadam C, Abhang SA. Evaluation of serum levels of reduced glutathione, glutathione-s-transferase and nitric oxide in breast cancer patients undergoing adjuvant chemotherapy Apoptosis markers in breast cancer therapy View project on diabetes View project. International Journal of Current Research and Review, (2014); 5 (13):51–7.
Yun CC. Lysophosphatidic Acid and Autotaxin-associated E ff ects on the Initiation and Progression of Colorectal Cancer. Cancers, (2019); 11(958):1–19.
Li Y, Zhang L, Xu T, Zhao X, Jiang X, Xiao F, et al. Aberrant ENPP2 expression promotes tumor progression in multiple myeloma. Leukemia and Lymphoma, (2022); 63(4): 963–974.
Tang X, Benesch MGK, Brindley DN. BBA - Molecular and Cell Biology of Lipids Role of the autotaxin – lysophosphatidate axis in the development of resistance to cancer therapy. BBA - Molecular and Cell Biology of Lipids, (2020); 1865(8): 1-13.
Brindley DN, Lin FT, Tigyi GJ. Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, (2013); 1831(1): 74–85.
Parra V, Eisner V, Chiong M, Criollo A, Moraga F, Garcia A, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovascular Research, (2008); 77(2): 387–97.
DOI: http://dx.doi.org/10.62940/als.v10i0.2059
Refbacks
- There are currently no refbacks.